QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2

Cancer Biology and Therapy

Volumn 15, Issue 9, 2014, Pages 1174-1184

  Lu, Wei ^a,b   Feng, Feixue ^a   Xu, Jinke ^a   Lu, Xiaozhao ^a   Wang, Shan ^a   Wang, Lifeng ^a   Lu, Huanyu ^a   Wei, Mengying ^a   Yang, Guodong ^a   Wang, Li ^a   Lu, Zifan ^a   Liu, Yanpu ^a   Lei, Xiaoying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 101 Hospital of Chinese PLA   (China)

Author keywords

Cancer stem cell; Oral cancer; QKI; Self renewal; SOX2

Indexed keywords

3' UNTRANSLATED REGION; QKI PROTEIN, HUMAN; RNA BINDING PROTEIN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

3' UNTRANSLATED REGION; ANIMAL; CANCER STEM CELL; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; RNA-BINDING PROTEINS; SOXB1 TRANSCRIPTION FACTORS;

EID: 84906839788     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.29502     Document Type: Article

References (32)

1. da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, et al. Advances and applications of oral cancer basic research. Oral Oncol 2011; 47:783-91; PMID:21802978; http://dx.doi.org/10.1016/j.oraloncology.2011.07.004
2. de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP. Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck 2010; 32:357-67; PMID:19644932
3. Huang SH, O'Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 2013; 18:e233-40; PMID:23385513; http://dx.doi.org/10.4317/medoral.18772
4. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009; 31:748-58; PMID:19189340; http://dx.doi.org/10. 1002/hed.21022
5. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011; 9:50-63; PMID:21726833; http://dx.doi.org/10.1016/j.stem.2011.06.005
6. Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell 2007; 1:241-2; PMID:18371356; http://dx.doi.org/10.1016/j.stem.2007.08.012
7. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131:1109-23; PMID:18083101; http://dx.doi.org/10.1016/ j.cell.2007.10.054
8. Zhang Z, Filho MS, Nör JE. The biology of head and neck cancer stem cells. Oral Oncol 2012; 48:1-9; PMID:22070916; http://dx.doi.org/10.1016/j. oraloncology.2011.10.004
9. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 2010; 289:151-60; PMID:19748175; http://dx.doi.org/10.1016/j.canlet.2009.08.010
10. Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21:283-96; PMID:22439924; http://dx.doi.org/10.1016/j.ccr.2012.03.003
11. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-76; PMID:16904174; http://dx.doi.org/10.1016/j.cell.2006.07.024
12. Hussenet T, du Manoir S. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 2010; 9:1480-6; PMID:20372069; http://dx.doi.org/10.4161/cc.9.8.11203
13. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P, Radlwimmer B. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 2010; 49:9-16; PMID:19787784; http://dx.doi.org/10.1002/gcc.20714
14. Biedermann B, Hotz HR, Ciosk R. The Quaking family of RNA-binding proteins: coordinators of the cell cycle and differentiation. Cell Cycle 2010; 9:1929-33; PMID:20495365; http://dx.doi.org/10.4161/cc.9.10.11533
15. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr., Jungkamp AC, Munschauer M, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010; 141:129-41; PMID:20371350; http://dx.doi.org/10.1016/j.cell.2010.03. 009
16. Galarneau A, Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 2005; 12:691-8; PMID:16041388; http://dx.doi.org/10.1038/nsmb963
17. Chénard CA, Richard S. New implications for the QUAKING RNA binding protein in human disease. J Neurosci Res 2008; 86:233-42; PMID:17787018; http://dx.doi.org/10.1002/jnr.21485
18. Wang X, Sun W, Bai J, Ma L, Yu Y, Geng J, Qi J, Shi Z, Fu S. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma. Mol Biol Rep 2009; 36:861-9; PMID:18418730; http://dx.doi.org/ 10.1007/s11033-008-9256-x
19. O'Brien CA, Kreso A, Ryan P, Hermans KG, Gibson L, Wang Y, Tsatsanis A, Gallinger S, Dick JE. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 2012; 21:777-92; PMID:22698403; http://dx.doi.org/10.1016/j.ccr.2012.04.036
20. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004; 6:R605-15; PMID:15535842; http://dx.doi.org/10.1186/bcr920
21. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66:9339-44; PMID:16990346; http://dx.doi.org/10.1158/0008-5472.CAN-06-3126
22. Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med 2009; 15:1010-2; PMID:19734877; http://dx.doi.org/10.1038/nm0909-1010
23. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6:603-15; PMID:20569697; http://dx.doi.org/10.1016/j.stem.2010.04.001
24. Teplova M, Hafner M, Teplov D, Essig K, Tuschl T, Patel DJ. Structure-function studies of STAR family Quaking proteins bound to their in vivo RNA target sites. Genes Dev 2013; 27:928-40; PMID:23630077; http://dx.doi.org/10.1101/gad.216531.113
25. Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 2013; 12:15-30; PMID:23290134; http://dx.doi.org/10.1016/j.stem.2012.12.007
26. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, Sun L, Yang X, Wang Y, Zhang Y, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 2008; 283:17969-78; PMID:18456656; http://dx.doi.org/10.1074/jbc.M802917200
27. Yang G, Fu H, Zhang J, Lu X, Yu F, Jin L, Bai L, Huang B, Shen L, Feng Y, et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010; 138:231-40, e1-5; PMID:19686745; http://dx.doi.org/10.1053/j.gastro.2009.08.001
28. Zhao Y, Zhang G, Wei M, Lu X, Fu H, Feng F, Wang S, Lu W, Wu N, Lu Z, et al. The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein. Cancer Biol Ther 2014; 15:108-18; PMID:24153116; http://dx.doi.org/10.4161/cbt.26722
29. Bian Y, Wang L, Lu H, Yang G, Zhang Z, Fu H, Lu X, Wei M, Sun J, Zhao Q, et al. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. Biochem Biophys Res Commun 2012; 422:187-93; PMID:22569043; http://dx.doi.org/10.1016/j.bbrc.2012.04.138
30. Ji S, Ye G, Zhang J, Wang L, Wang T, Wang Z, Zhang T, Wang G, Guo Z, Luo Y, et al. miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer. Gut 2013; 62:716-26; PMID:22490519; http://dx.doi.org/10.1136/gutjnl-2011-301083
31. Alison MR, Lin WR, Lim SM, Nicholson LJ. Cancer stem cells: in the line of fire. Cancer Treat Rev 2012; 38:589-98; PMID:22469558; http://dx.doi.org/10. 1016/j.ctrv.2012.03.003
32. Chen Y, Tian D, Ku L, Osterhout DJ, Feng Y. The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation. J Biol Chem 2007; 282:23553-60; PMID:17575274; http://dx.doi.org/10.1074/jbc.M702045200